Biesse SpA
MIL:BSS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biesse SpA
MIL:BSS
|
IT |
|
A
|
Abbott Laboratories
DUS:ABL
|
US |
|
J
|
JMT Network Services PCL
SET:JMT
|
TH |
|
W
|
Wartsila Oyj Abp
XMUN:MTA
|
FI |
|
W
|
Welltower Inc
F:HCW
|
US |
|
Compagnie de Saint Gobain SA
OTC:CODGF
|
FR |
|
E
|
Emmerson Resources Ltd
F:42E
|
AU |
|
S
|
Snam SpA
XMUN:SNM
|
IT |
|
H
|
HWA AG
XMUN:H9W
|
DE |
|
C
|
Coty Inc
F:CO3A
|
US |
|
T
|
Tractor Supply Co
XBER:TR4
|
US |
|
M
|
MaxCyte Inc
NASDAQ:MXCT
|
US |
|
I
|
Investec PLC
F:IVKA
|
UK |
|
G
|
Grupo Aeroportuario del Centro Norte SAB de CV
XBER:G7A
|
MX |
|
E
|
Esperion Therapeutics Inc
F:0ET
|
US |
|
P
|
Proto Labs Inc
XMUN:PRZ
|
US |
Wall St Price Targets
BSS Price Targets Summary
Biesse SpA
According to Wall Street analysts, the average 1-year price target for
BSS is 6.89 EUR with a low forecast of 5.56 EUR and a high forecast of 8.4 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BSS's stock price target?
Price Target
6.89
EUR
According to Wall Street analysts, the average 1-year price target for
BSS is 6.89 EUR with a low forecast of 5.56 EUR and a high forecast of 8.4 EUR.
What is the Revenue forecast for Biesse SpA?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 5%.